Market Research Blog – Page 9389 – New Product Development

Aromatherapy Increasing Research and Development Projects to Spell Growth of the Market

The global Aromatherapy Market is predicted to grow with a positive outlook by exhibiting growth at a CAGR of 8.1% over the projection period from 2022 to 2032. The global market is expected to be valued at around US$ 5.9 Billion in 2022 with a total estimation of around US$ 12.9 Billion by 2032. Aromatherapy is used for a variety of health-related advantages which is one of the predominant reasons to drive the industry growth over the assessment period. According to the historical analysis by Future Market Insights, the global aromatherapy market witnessed a significant surge at a registered CAGR of 6.5% from 2016 to 2021.

Request a Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1080

Aromatherapy is known as a holistic therapeutic alternative or a supplementary treatment that uses aromatic ingredients such as essential oils derived from plants. Aromatherapy is known as a medication with essential oils which helps in boosting the health of the body, mind, and spirit. It improves both physical and mental well-being. The aromatherapy sector is anticipated to predicted to surge immensely in the future attributed to its wide array of uses and low side effects. As more people become aware of the benefits of essential oils, the market will grow, particularly among patients suffering from skin disorders and acne.

Consumer choice for aromatherapy was immensely influenced by the Covid-19 pandemic. Due to surging scientific evidence supporting the numerous benefits bestowed by aromatherapy and topical essential oil therapies for pain relief in disorders such as dysmenorrhea, the market is expected to exhibit significant growth traction in the anticipated years. There are several hospital-based aromatherapy programs rapidly being built in developed nations, which is another major driver projected to support aromatherapy market expansion.

Key Takeaways

Several wellness professionals including spa therapists, aroma therapists, massage therapists, and gym trainers, prefer single and blended essential oils for the treatment of insomnia, anxiety, pain, agitation, stress, and other conditions because essential oils provide the desired therapeutic effects with minimal or no side effects. This is due to the fact that these treatments may be conducted without the use of medicines.
One of the crucial driving factors propelling the growth of the global aromatherapy industry is known to be its strong distribution network. Various essential oil markers are working on negotiating distribution arrangements with large retail corporations to make their goods available, which will result in greater penetration of aromatherapy treatments and products.
Aromatherapies are rapidly being preferred these days attributing their properties for relaxation is likely to contribute to the aromatherapy market’s revenue development. The development of inhalation aromatherapy for the treatment of sleep issues such as insomnia is significant market advancement.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-1080

Competitive Landscape

Dominant aromatherapy product manufacturers are employing multi-level marketing tactics in order to enhance product distribution and they are also considering hiring a large number of independent distributors. This has resulted in increased accessibility and affordability of aromatherapy goods are likely to stimulate global demand for essential oils and aromatherapy diffuser products.

An extensive marketing network of distributors is expected to benefit both global and local market participants. In addition to that, firms are providing their aromatherapy goods online, which are projected to assist the aromatherapy market’s growth.

More Insights into the Aromatherapy Market

North America is expected to dominate the global aromatherapy market owing to the presence of crucial market competitors in the region. The growth in the region is also attributed to the surging sales of crucial oil for home use, lifestyle changes, a growing urban population, and the increased influence of the media are all factors boosting demand for aromatherapy goods in the region.

The aromatherapy market in Europe is expected to rise significantly over the forecast period. The rising popularity of aromatherapy as a therapeutic and pharmacological alternative is expected to drive market expansion in Europe. The majority of essential oils are sold in European nations including the United Kingdom, Germany, the Netherlands, Belgium, and Ireland.

Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-1080

Key Segments Covered in the Aromatherapy Industry Analysis

Aromatherapy Market by Product:

Aromatherapy Consumables
- Essential Oils
  - Floral
  - Citrus
  - Herbaceous
  - Spicy
  - Woodsy
  - Earthy
  - Camphorous
  - Others
- Blended Oils
- Carrier Oils
Aromatherapy Equipment
- Nebulizing Diffusers
- Ultrasonic Diffusers
- Evaporative Diffusers
- Heat Diffusers

Aromatherapy Market by Application:

Relaxation
Insomnia
Pain Management
Scar Management
Skin & Hair Care
Cold & Cough
Others

Aromatherapy Market by Mode of Delivery:

Topical Application
Direct Inhalation
Aerial Diffusion

Aromatherapy Market by Distribution Channel:

Aromatherapy Products Sold at Retail Shops
Aromatherapy Products Sold through Online Channels
Direct Distribution of Aromatherapy Products

Buy Complete Report@ https://www.futuremarketinsights.com/checkout/1080

Have a Look at Latest Related Reports of Healthcare Domain

Rib Fracture Repair Systems Market:- The Rib Fracture Repair Systems Market is expected to reach US$ 420.3 million in 2022 and is projected to increase at a CAGR of 5.2% to reach US$ 699.5 million by 2032.

Microbial Gene Editing Market:- Microbial Gene Editing is technology which have the ability to change the DNA of organism. Microbial gene editing is changing the ways for developing new medical treatment.

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Pharmacy Automation Systems Market Latest Developments and Innovations Across the Industry

The global Pharmacy Automation Systems Market is projected to reach a value of about US$ 10.6 Bn by 2032, with the market growing at a strong CAGR of 8.0% from 2022 to 2032. Valued at US$ 4.6 Mn in 2021, the target market will likely reach US$ 4.9 Bn in 2022. The elevated usage of the pharmacy automation system in drug dispensing & packaging, drug storage, and inventory management is fueling the market growth of the same. Rising interest in automating the daily operations of pharmacies all over the world is supplementing the growth of the pharmacy automation systems market during the forecast period.

Request a Report Sample @
https://www.futuremarketinsights.com/reports/sample/rep-gb-5079

Hospital and retail pharmacies are major contributors to the pharmacy automation systems market. More and more pharmacies across the world are adopting pharmacy automation systems to automate day-to-day activities to reduce human intervention, enhance operational efficiency, and lessen overstocking. These systems are used by both inpatient and outpatient pharmacies. Pharmacy automation systems also include properties like the ability to measure personalized medications, track and update consumers’ information in a database, and monitor the all-over procedure of inventory management and distribution.

Consequently, they are a suitable replacement for manual dispensing across drugstores. The installation of these systems has immensely improved the efficiency and security of storing, administering, filling, packaging, and labeling prescription medications. These considerations, coupled with other factors like the introduction of cost-effective automation solutions, incorporation of advancing technology into the target product, etc., are likely to drive the growth of the pharmacy automation systems market during the forecast period.

Furthermore, the rising awareness of the benefits of pharmacy automation technologies is encouraging many small and mid-sized healthcare hospitals and retail pharmacies to replace their traditional pharmacy operation practices with these systems. This will boost the market prospects during the next decade.

“Rising awareness of the advantages of pharmacy automation systems along with favorable government policies will supplement the global growth of the pharmacy automation systems market over the forecast period,” says an FMI analyst.

Key Takeaways:

By end user, the hospital pharmacies segment will grow at a high CAGR over the forecast period.
On the basis of application, drug dispensing and packaging will continue to dominate the global market growth.
Accounting for 42.6% of the market share in 2021, the medication dispensing cabinets will present a steady growth over the assessment period.
Germany’s pharmacy automation systems market will register a 7.9% CAGR.
The pharmacy automation systems market in the U.S. will acquire a 56.6% share of the global market.
Increasing number of pharmacies drives the target market growth in India.

Get More Information on this Report @
https://www.futuremarketinsights.com/reports/pharmacy-automation-systems-market-092017

Competitive Landscape

AmerisourceBergen Corporation, Baxter International Inc., Swisslog Holdings AG, Care Fusion Corporation, Cerner Corporation, Kirby Lester LLC, Talyst, LLC., Omnicell Inc., and ScriptPro LLC among others are some of the major players in the pharmacy automation systems market profiled in the full version of the report.

Key market players are keen on adopting tactics such as new product releases and increasing investments in research and development. These organizations are also focusing on employing mergers, acquisitions, partnerships, and collaboration strategies to expand their consumer base.

More Insights into Pharmacy Automation Systems Market Report

In its latest report, FMI offers an unbiased analysis of the global pharmacy automation systems market, providing historical data from 2014 to 2021 and forecast statistics for 2022 to 2032. To understand the global market potential, growth, and scope, the market is segmented on the basis of product type (robotic dispensing machines, carousel storage, tablet splitters), application (drug dispensing & packaging, drug storage, inventory management), end user (hospital pharmacies, clinic pharmacies, retail pharmacies, mail order pharmacies, pharmaceutical SME’s), and region.

According to the latest FMI reports, based on segmentation, the medication dispensing cabinets segment will demonstrate steady growth owing to its higher rate of adoption. The drug dispensing and packaging segment held 47% of the market share in 2021 and will likely retain its lead while the hospital pharmacies segment is anticipated to register a high CAGR during the projection period.

Based on region, the pharmacy automation systems market in Germany is projected to exhibit substantial growth, recording a positive CAGR of 7.9% during 2022-2032. A well-established and advancing healthcare sector, a rising geriatric population, growing concerns regarding improper inventory management, and the high cost of storing inventory are certain considerations that drive the growth of the target market in this country. Germany accounted for 3.3% of the global pharmacy automation systems market share in the year 2021. Other countries like India and the United States are predicted to present impressive growth in the pharmacy automation systems market over the forecast period.

Report for Customization @
https://www.futuremarketinsights.com/customization-available/rep-gb-5079

Key Market Segments Covered in Pharmacy Automation Systems Industry Research

By Product:

Medication Dispensing Cabinets
Packaging & Labelling Machines
IV Pharmacy
Robotic Dispensing Machines
Carousel Storage
Tablet Splitters

By Application:

Drug Dispensing & Packaging
Drug Storage
Inventory Management

By End User:

Hospital Pharmacies
Clinic Pharmacies
Retail Pharmacies
Mail Order Pharmacies
Pharmaceutical SME’s

Request for Methodology @
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-5079

Top Reports Related to Healthcare Market Insights

Digital X-ray equipment Market:- Digital X-ray Equipment Market is projected to expand at an exceptional double-digit CAGR from 2022-2032.

Micro Guide Catheters Market:- Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic-era to focus on the growth and development of the Micro Guide Catheters Market.

About Future Market Insights (FMI)

Contact:

Pulmonology Devices Market Report 2022: Consistent Levels of R&D Driving Sector Growth

The global Pulmonology Devices Market is expected to grow at a steady rate over the forecast period. The market for pulmonology devices will demonstrate substantial growth in the upcoming years. Heightened prevalence of respiratory disorders like asthma, lung cancers, chronic obstructive pulmonary disorders (COPD), and cystic fibrosis fuel the pulmonology devices market to grow at a robust CAGR of about 10.7%during the projected period.

Get Access To Sample Now: https://www.futuremarketinsights.com/reports/sample/rep-gb-13036

Increased air pollution, a rise in the number of industrial & chemical pollutants which decrease the quality of air, and a surge in the geriatric population have led to a rise in the cases of various respiratory illnesses. The rising incidences of these diseases have resulted in an elevated demand for new and innovative techniques for accurate diagnosis and treatment and consequently fuel the growth of the pulmonology devices market in the coming years.

Additionally, favorable reimbursement enforced for outpatient procedures is a factor that will positively impact the prospect of the pulmonology devices market. The target market will further benefit from the surge in the adoption of technologically advanced pulmonology devices. Again, rising public awareness about respiratory conditions has amplified the adoption rates of these devices.

Though the target market has bright prospects lined up over the next few years, the market is not without its share of challenges. Concerns over the safety of pulmonary devices coupled with their expensiveness will likely hamper the market growth during this period of observation.

“Growing cases of respiratory diseases coupled with the introduction of technologically advanced devices is expected to drive the global growth of pulmonology devices market over the forecast period,” says an FMI analyst.

Key Takeaways:

High cost of the equipment will hamper the pulmonology devices market.
Brazil is expected to emerge as a potential market with several lucrative opportunities for pulmonology devices market.
The presence of a well-established healthcare market fuels the growth of the pulmonology devices market in Japan.
Single-use bronchoscopes are expected to acquire the highest share of the global pulmonology devices market.
On the basis of end-user, hospitals will continue to lead the market growth.
By indication, the high prevalence of COPD is a prime contributor to the pulmonology devices market.

Customization Report Before Buying, Visit: https://www.futuremarketinsights.com/customization-available/rep-gb-13036

Competitive Landscape

Boston Scientific Corporation, CONMED Corporation, Olympus Corporation, Cook Medical Incorporated, and Ambu A/S Major Manufacturers, Verathon, Inc., United Medical Surgical Services Ltd., Hunan Vathin, Micro-Tech (Nanjing) Co., Ltd, Merit Medical Systems, and others are some of the major players in the pulmonology devices market profiled in the full version of the report.

Key companies in this market are concentrating on developing a wide range of advanced products. These businesses are also adopting tactics like acquisitions and mergers to improve their global market presence.

Request Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-13036

More Insights into Pulmonology Devices Market Report

In its latest report, FMI offers an unbiased analysis of the global pulmonology devices market, providing historical data from 2015 to 2019 and forecast statistics for 2020 to 2030. To understand the global market potential, growth, and scope, the market is segmented on the basis of product type (pulmonary biopsy devices (single-use biopsy forceps, cytology brushes, microbiology brushes), endobronchial ultrasound (EBUS) needles (endobronchial ultrasound fine biopsy needles, endobronchial ultrasound transbronchial aspiration needles), airway stent (silicon stents, nitinol stents, stainless steel stents), airway extraction baskets, single-use bronchoscopes), indication (lung cancer, COPD, foreign body extraction, tracheal and bronchial stenosis, others), end user (hospitals, pulmonology clinics, ambulatory surgical centers), and region.

According to the latest FMI reports, based on segmentation, the high prevalence of COPD immensely contributes to the expansion of the pulmonology devices market. In terms of product type, single-use bronchoscopes are predicted to register heightened demand whereas hospitals will continue to remain the top end-user during the forecast period.

Based on region, the pulmonology devices market in the United States is anticipated to demonstrate substantial growth. Technological advancements augment the sales of minimally invasive surgery products. This coupled with heightened demand for such products in the country is driving the growth of the pulmonology devices market in the U.S. The U.K. and Japan are two other countries that are predicted to undergo notable growth in the pulmonology devices market during the forecast period.

Other Trending Report:

Optical Imaging Market:- Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic-era to focus on the growth and development of the Optical Imaging Market.

High-Resolution Anoscopy Market:- The global High-Resolution Anoscopy Market is poised to register a CAGR of 6% to reach a valuation of US$ 24.95 Bn by 2032, up from US$ 13.93 Bn in 2022.

Abdominal Closure Systems Market:- Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic-era to focus on the growth and development of the Abdominal Closure Systems Market. The study features insights on the current growth dynamics and the major revenue reforms prevailing in the market as along with the key takeaways over the forecast.

About Future Market Insights (FMI)

Contact:

Empty Capsules Market Insights, New Innovations, Research and Growth Factor till 2026

The global sales of Empty Capsules Market are expected to create lucrative growth opportunities over the projection period from 2022 to 2026 with a wealthy CAGR of 8%. The global market is expected to reach around US$ 2.1 Bn in 2022 and surpass a valuation of US$ 2.9 Bn by 2026. At present, the empty pill capsule market accounts for around 1% of the global drug delivery market. The flexibility of such fillable capsules is anticipated to gradually promote the use of empty pills in the nutraceutical and pharmaceutical sectors.

Get a Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-782

Owing to the surging consumption of various drugs combined with the increasing popularity of capsules over several other drug delivery forms is a primary factor boosting sales of empty capsules. Since the burden of chronic diseases continues to rise, demand for therapeutics is anticipated to increase at a substantial pace. This is in turn expected to generate lucrative growth prospects for the suppliers of empty capsules.

Empty capsules are known as protective shells for drugs designed from special film-forming materials such as gelatin, starch, and pullulan. Being innovative drug delivery products, they are utilized by leading pharmaceutical and biopharmaceutical companies due to their various attractive features. Such capsules are economical, oxidation resistant, offer maximum flexibility, and are easy to use on account of their smooth and slippery nature. Furthermore, they are especially suitable for substances having a bitter taste and unpleasant odor.

Key Takeaways

The market is subjected to change in relevance in order to get regulatory impositions of gelatin sourcing and licensing for distribution, as per the macro and industry standards. The prominent driver in the global empty capsules market incorporates the development of natural alternatives to raw material sourcing of gelatin.
In addition to that, efficient packaging of empty capsules has proven to improve the integrity of the product and avoid contamination. It has also offered several solutions for the efficient dissolution of the capsules and is therefore expected to enhance the sales outlook of the empty capsules market during the forecasted years.
Empty capsules have proven to be an ideal drug delivery product as they account for their ability to protect sensitive substances from oxidation as well as their user-friendly nature. These capsules are usually smooth and slippery which makes them easy to swallow.
The use of empty capsules is diverse within the healthcare sector as they are expletively utilized by pharmaceutical and biopharmaceutical companies to encapsulate liquids, powders, granulates, oils, extracts, and even herbs. Surging production and consumption of empty capsules to cater to the rising demand from the pharmaceutical industry will continue to boost the empty capsules market growth during the assessment period.
Over the last few years, encapsulated capsules have garnered major traction for the encapsulation of unpalatable medicines. The empty capsule suppliers are using various strategies to increase sales. They are focusing on developing innovative capsule materials that not only help to deliver medicine but also perform other functions as well. This will help them to lure more and more customers.

Visit for Customization @
https://www.futuremarketinsights.com/customization-available/rep-gb-782

Competitive Landscape

The global empty capsules market is known to be highly competitive in nature attributed to the presence of leading empty pill manufacturers that account for over 70% of the global market share. Prominent market players are constantly focusing on introducing new products designed out of innovative materials. In addition to that, they are adopting growth strategies such as partnerships, mergers, acquisitions, etc. to expand their global footprint.

More Insights into the Empty Capsules Market

The U.S. is expected to dominate the global empty capsules market as it accounts for a massive chunk of the global market. The growth of the market is attributed to the poor lifestyle habits in the U.S. which have resulted in a substantial increase in demand for nutraceuticals to adjust proper nutrient intake, subsequently driving sales of empty supplement capsules and empty vitamin capsules.

Moreover, surging awareness associated with vegetarian empty capsules and the availability of technologically advanced empty capsule filling machines will propel sales of empty HPMC capsules and empty pullulan capsules in the U.S. through 2030.

Japan is the second largest consumption of empty medicine capsules owing to increasing usage by the geriatric population and growing consumer awareness about the benefits of capsules over other forms.

Key Segments of Empty Capsules Industry Survey

Capsule Size:

Size “000” Empty Capsules
Size “00” Empty Capsules
Size “0” Empty Capsules
Size “1” Empty Capsules
Size “2” Empty Capsules
Size “3” Empty Capsules
Size “4” Empty Capsules
Size “5” Empty Capsules

Product Type:

Gelatin (Hard)-based Capsules
Vegetarian-based Capsules

Route of Administration:

Empty Capsules for Oral Administration
Empty Capsules for Inhalation

Raw Material:

Contract Type-A (Pork Skin) Empty Capsules
Type-B Gelatin (Animal Bones & Calf Skin) Empty Capsules
Fish Bone Gelatin Empty Capsules
Empty Hydroxy Propyl Methyl Cellulose (HPMC) Empty Capsules
Starch Material Empty Capsules
Empty Pullulan Capsules

End User:

Empty Capsules for Pharmaceutical Companies
Empty Capsules for Cosmetic & Nutraceutical Companies
Empty Capsules for Clinical Research Organizations (CROS)

Further Assistance in Purchasing this Report @
https://www.futuremarketinsights.com/checkout/782

Explore FMI’s Extensive Coverage on Healthcare Domain

Pressure Infusion Cuffs Market: The Pressure Infusion Cuffs are designed cuff and bladder device used to pressurize sterile parenteral fluids for rapid infusion into the body. These decrease the infusion time to a few seconds from hour taken by gravity fed blood infusion.

Women Health Applications Market: According to the study, The worldwide Women Health Applications Market is assessed at US$ 3.4 Bn in 2022 and is projected to arrive at a valuation of US$ 24 Bn by 2032, growing at a CAGR of 21.6% through the figure time of 2022-2032.

Pulse Lavage Market: Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic-era to focus on the growth and development of the Pulse Lavage Market. The study features insights on the current growth dynamics and the major revenue reforms prevailing in the market as along with the key takeaways over the forecast.

About Future Market Insights (FMI)

Contact:

U.S. Animal Model Market is expected to increase at a high CAGR of 4.1 % 2022-2032

As per Future Market Insights’ latest industry analysis, the U.S. animal model market was valued at over US$ 921.9 Mn in 2021 and is anticipated to exhibit a CAGR of close to 4.1% over the forecast period (2022-2032).

Animal models are predominantly used to gather information regarding the disease and its prevention, diagnosis, and treatment. They are being used to resolve a wide range of scientific concerns, ranging from basic science to the discovery and evaluation of new vaccines and therapies. Animals are used because of the similarities in biology across most mammals.

Get Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14527

Personalized medicine is also known as precision medicine which utilizes data about a specific patient or an individual’s genes to plan treatment for a disease. Animal models can play important role in the development of new approaches for personalized medicine. Increasing adoption of personalized medicine will drive sales of animal model in the forthcoming years.

Toxicity testing in animals is done to discover potential side effects from an agent’s exposure and to generate dose-response relationships. Animal testing is important for the early detection of the potential risk to humans or as models to study the causes, pathogenesis, progression, and treatment of diseases.

Organizations and legislations such as the Federal Food, Drug, and Cosmetic Act (FFDCA), Environmental Protection Agency (EPA), Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), and Organization for Economic Co-operation and Development (OECD) determine the testing guidelines for toxicity testing on animals.

Some factors such as the high production volume of chemicals testing in the U.S., increasing generation and utilization of novel GM animal strains in toxicity studies, and the development and attempted validation of several animal tests to screen chemicals for endocrine (hormone)-disrupting activity are expected to drive the growth in the market.

For in-depth insights, Download a PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14527

Key Takeaways:

Based on species, the mice model segment is expected to hold nearly 62.6% of the total market share 2022, with sales growing at a 5.1% CAGR.
In terms of therapeutics, the oncology accounted for more than 32.0% of the total market share in 2021, and the trend is expected to continue over the forecast period.
By application, sales in the drug discovery/development segment commanded 65.4% of the total market share in 2021.
Based on end user, the academic & research institutes segment accounted 36.6% of the total market share in 2021.

Key Players:

Charles River Laboratories
The Jackson Laboratory
Taconic Biosciences, Inc.
Genoway
Envigo (Inotiv, Inc.)
Marshall BioResources
Janvier Labs
Applied stem cells
Biocytogen
Transposagen Biopharmaceuticals, Inc. (Hera Bio Labs)
Cyagen
Ingenious targeting labs
Crown Bioscience Inc. (JSR Corporation).
Harbour Biomed
Sinclair Bio Resources
Alpha Genesis Inc.
Creative Animodel
DaVinci Biomedical Research Products, Inc

For in-depth competitive analysis, Buy Now @ https://www.futuremarketinsights.com/checkout/14527

Market Competition

Key players operating in the U.S. animal model market are expanding their business through partnerships and acquisitions with other companies to improve their global footprint. Following are a few examples of acquisitions:

In October 2021, The Jackson Laboratory completed the acquisition of Charles River Laboratories Japan’s Research Models & Services (RMS), which allows advancement in the company’s scientific improvements in basic research and drug discovery.
In November 2021, Inotiv, Inc., which is a leading contract research organization (CRO) completed its acquisition of Envigo RMS Holding Corp. to expand its R&D sector.
In February 2021, Biocytogen completed the acquisition of a third Beacon Optofluidic system. This acquisition expanded Biocytogen’s service platform in the Boston area.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the animal model market in its latest study, presenting a historical demand assessment of 2017–2021 and projections for 2022– 2032.

The research study is based on the species – (rats, mice, pigs, rabbits, monkeys, dogs, cats, other species), therapeutics- (metabolic diseases, cardiovascular diseases, neurological diseases, and oncology), application (drug discovery/development and basic & applied research) end-user (academic & research institutes, pharmaceutical companies, biotechnology companies, and CROs) and across seven key regions of the world.

Future Market Insights’ Expertise in Life Sciences and Transformational Health

Our expert team of industry analysts comprising management graduates, medical professionals, engineers, and project managers provides insights on emerging therapy areas, diagnostic tools, medical devices and components, reimbursement and market access, biotechnology, and life science research products and services to equip decision-makers with sound inputs and strategic recommendations.
About FMI:

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports : https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Self-testing Market projected to progress at a noteworthy CAGR of 5.6% to reach US$ 11.55 Bn by 2030-end

As per the latest market study by Future Market Insights (FMI), the global self-testing market is projected to record a CAGR of 5.6% amid the forecast period, 2022-2030.

Self-testing Market Size (2022)	US$ 7.49 Bn
Revenue Forecast (2030)	US$ 11.55 Bn
Global Market Growth Rate (2022-2030)	5.6% CAGR
Dominant Sample Type	Urine (45.1%)

Consumers are swiftly adapting to buy self-testing kits due to early detection of severe allergies or diseases with the assistance of STI/STD self-tests, cancer-tests, and intolerance self-tests. Pharmacies are receiving a positive response online against the conventional approach of buying them from retail pharmacy stores subsequent to seeking medical advice. Market players are formulating these testing kits together with a range of wellness and prevention strategies, scoping from chronic disorder management and acute infection diagnoses to detecting probable risks of diseases.

Get a Sample Copy of the Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-7914

Moreover, the COVID-19 outbreak and successive ripple effects have obliged retailers to shut down their stores, impacting the profit margins of self-testing kit producers. With brick-&-mortar stores closing down temporarily, players are placing their bets on e-commerce/online platforms to endure pandemic shockwaves.

“Easy accessibility of product via online pharmacies or retail pharmacies is promising the producers to enter into an agreement with distribution and supply chain networks to enter untapped markets and establish a global footprint,” opines FMI analyst.

Self -Testing Market – Major Takeaways

The global self testing market is forecasted to reach a valuation of US$ 11 Bn by 2030.
By product, digital monitoring instruments will continue to be the preferred product category as they help care for ailments ranging from chronic to recovery conditions from acute episodes by gathering important patient data at-home settings.
Based on the application, around 8 out of 10 users opt for utilizing these kits for testing blood glucose.
Among distribution channels, the retail pharmacies will remain dominant attaining revenue close to US$ 3.5 Bn, by 2030.

Self -Testing Market – Key Drivers

Demand for reliable and easy self-testing devices and kits has escalated owing to the fast generation of results along with maintaining the privacy.
Easy accessibility and advertising schemes are influencing the self-testing market growth, optimistically.
Growing awareness concerning healthcare and related ailments along with non-profit organizations and government’s encouragement complements the market growth.

Self -Testing Market – Regional Analysis

North America remains the biggest market for self-testing kits, worldwide, trailed by Europe, due to mature healthcare infrastructure and favorable government policies.
The European region is anticipated to be the second most lucrative region owing to the increasing occurrence of diabetics and the growing adoption rate.
East Asia self-testing kits market is foreseeing huge demand, soaring investments in healthcare infrastructure up-gradation in addition to increasing trend of home diagnosis.

Ask An Analyst @ https://www.futuremarketinsights.com/askus/rep-gb-7914

Self -Testing Market – Competitive Landscape

Market players extend to reap notable revenues from retail pharmacies. Conversely, they are additionally delving into new revenue streams in supermarkets/hypermarkets and online pharmacies. Prominent players operating in the global self-testing market include ARKRAY Inc., ACON Laboratories Inc., Becton, Dickinson & Company, Assure Tech (Hangzhou) Co. Ltd., Roche Holding AG, Bionime Corporation, True Diagnostics Inc., and Quidel Corporation.

Self- Testing Market – Taxonomy

Product

Digital Monitoring Instruments
Midstreams
Cassettes
Cups
Strips
Test Panels
Dip Cards
Others

Application

Pregnancy & Fertility Testing
Blood Glucose Testing
STD/ STI Testing
Cancer Testing
Cholesterol Testing
Drug of Abuse Testing
Thyroid Testing
HIV Testing
Others

Sample

Blood
Urine
Stool
Saliva
Semen
Vaginal Swab

Buy Complete Report@ https://www.futuremarketinsights.com/checkout/7914

Distribution Channel

Drug Stores
Retail Pharmacies
Supermarket/Hypermarket
Online Pharmacies

Regional Outlook:

North America
Latin America
Europe
South Asia & Pacific
East Asia
Middle East & Africa (MEA)

Get Valuable Insights into the Self Testing Market

Future Market Insights, in its new offering, provides an unbiased analysis of the global self testing market, presenting historical demand data and forecast statistics for the period from 2020-2030. The study divulges compelling insights on the self testing market, allowing readers to glean qualitative and quantitative information which will enable them to make informed market decisions in the upcoming forecast period.

About FMI:

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Antibiotic Susceptibility Testing Market is expected to reach a valuation of US$ 4.05 Bn by 2028

A recently published research intelligence on the global antibiotic susceptibility testing market by Future Market Insights tracks the top five influencers pushing demand and revenue growth of the market at a global level.

Infectious diseases, prevailing at a high pace
Increasing rate and tenure of hospitalization
Growing significance of early diagnostics
Soaring research interests in microbial susceptibility testing
Improving funding scenario for research, driven by governments & private bodies
Antibiotic Susceptibility Testing Market is expected to reach a valuation of US$ 4.05 Bn by 2028, expanding at a CAGR of 5.2%

Growing use of antibiotics in treating even the most common health conditions remains a strong factor boosting demand for antibiotic susceptibility testing (AST).

Increasing government funds for microbial and antibiotic susceptibility testing research and consistently improving outcome of PPPs in terms of enhanced screening and evaluation of antibiotics are playing a pivotal role in strengthening the performance of antibiotic susceptibility testing market.

CDC’s ‘AMR Challenge’ involving bioMérieux is a recently announced as objective to accelerate research efforts in the field of microbial resistance.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-8574

Research in Screening of High Pathogen Concentration Samples to Propel Demand for AST

The process of spotting a specific set of genes responsible for antibiotic resistance is highly complicated when it comes to handling the complexities associated with samples that have high concentration of pathogens.

Some of the highly desirable antibiotic susceptibility testing systems that allow direct-from-sample pathogen identification through high pathogen concentration samples, are thus likely to gain high traction in coming years.

Growing research efforts in the recognition of the presence of a specific set of antibiotic resistant genes can direct efforts for identification and selection of narrow-spectrum antibiotics, which remains among the most prominent factors pushing installed base of such antibiotic susceptibility testing equipment.

A few recent launches in this segment include Genmark Diagnostics’ ePLEX Blood Culture ID Panel, Biomerieux’s BioFire FilmArray, and Luminex Corp.’s Verigene Bloodstream Infection Panel.

The report also sheds light on the increasing role of Ecommerce in the market by boosting the availability of antibiotic susceptibility testing systems. Offering improved access to susceptibility testing devices by industry’s leading brands, online retail operators have been attracting prominent vendors in the global antibiotic susceptibility testing market.

A number of vendors dealing in antibiotic susceptibility testing equipment are opting for devices that are available online owing to the significantly reduced costs and additional discounts on price.

Entry of Technologically Advanced AST Systems to Favor Market Growth

As indicated by research, the sales of antibiotic susceptibility testing equipment will witness healthy growth owing to increasing demand for specific susceptibility testing systems to define the scope of targeted therapy.

Targeting key pathogens is imperative to design a highly specific plan of treatment for a particular patient, and antibiotic susceptibility testing systems efficiently allow researchers to achieve it within a significantly short timeline.

With FDA approving a considerable number of antibiotic and microbial susceptibility testing equipment, especially in the recent past, FMI forecasts an impressive installed base for antibiotic susceptibility testing systems in coming years.

Advanced technology enabled antibiotic susceptibility testing equipment allows early diagnosis that in turn improves chances of developing targeted therapy earlier. One such recent advancement enjoying visibly growing traction in market includes oCelloScope.

This antibiotic susceptibility testing equipment by BioSense Solutions is an optical susceptibility screening system with the capability to deliver real-time, time-lapse imaging of multiple microbial combinations, simultaneously.

Recently, Thermo Fisher Scientific, Inc. and Becton, Dickinson and Company received FDA approvals for their new launches in antibiotic susceptibility testing space. Moreover, FDA passed an approval to a susceptibility testing device by bioMérieux that has an expanded capability to identify a particular pathogen.

Browse Full Report:

https://www.futuremarketinsights.com/reports/antibiotic-susceptibility-testing-market

Market segmentation

Antibiotic Susceptibility Testing Market by Product:

Instruments
- Automated Broth Microdilution Systems
- Manual Broth Microdilution Systems
- Semi-automated Broth Microdilution Systems
Software & Services
- Image & Analysis Software
- Installation Services
Kits & Reagents

Antibiotic Susceptibility Testing Market by Application:

Sepsis
Respiratory Infections
Gastrointestinal Infections
Meningitis & Encephalitis
Endocarditis
Others

Antibiotic Susceptibility Testing Market by End User:

Diagnostic Laboratories
Hospitals
Research Laboratories

Antibiotic Susceptibility Testing Market by Region:

North America Antibiotic Susceptibility Testing Market
Latin America Antibiotic Susceptibility Testing Market
Europe Antibiotic Susceptibility Testing Market
East Asia Antibiotic Susceptibility Testing Market
South Asia & Pacific Antibiotic Susceptibility Testing Market
Middle East & Africa (MEA) Antibiotic Susceptibility Testing Market

Table of Content

Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

Market Introduction

2.1. Market Definition

2.2. Market Taxonomy

Global Antibiotic Susceptibility Testing Market Opportunity Analysis

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

Global Economic Outlook

4.1. Global Gross Domestic Product by Region & Country, 2013 – 2021

4.2. Healthcare Sector Outlook by Region & Country, 2013 – 2021

Key Inclusions

5.1. Development Roadmap for Antibiotic Susceptibility Testing Systems

5.2. Technology Assessment

Continued…!

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-8574

Have a Look at More Valuable Insights of Healthcare

Cystatin C Testing Market Size was valued at around US$ 194.3 Mn at the end of 2021. The market is projected to register a 7.5% CAGR and top a valuation of US$ 400.4 Mn by 2032

Topical Antibiotic Pharmaceuticals Market Share covering sales outlook, demand forecast & up-to-date key trends

Veterinary Antibiotics Market Demand is worth US$ 10,904.3 million in 2022. The veterinary antibiotics market is expected to expand at a sluggish CAGR of 5.8%, and reach US$ 20,277.5 million by 2032

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Interferons Market is projected to reach US$ 13.8 Billion by 2032 | Exclusive Report by FMI

[250 Pages Report] As per a latest industry analysis by Future Market Insights, the global interferons market was valued at around US$ 9.1 Bn in 2021 and is anticipated to exhibit a CAGR of 3.9% over the forecast period (2022-2032).

Attribute	Key Statistics
Global Interferons Market Estimated Size (2021E)	US$ 9.1 Bn
Projected Market Valuation (2032F)	US$ 13.8 Bn
Value-based CAGR (2022-2032)	3.9%
Collective Value Share: Top 5 Countries (2021E)	58.2%

A group of proteins produced by white blood cells, fibroblasts, and T-cells in response to viral infections, bacteria, tumor cells, and other pathogens are known as interferons. These glycoproteins, also known as cytokines, are frequently referred to as the first line of defense against pathogens.

Request Sample Copy of Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15158

Interferons have proved to be a cutting-edge and successful treatment option for illnesses such as cancer, hepatitis, and multiple sclerosis. In November 2021, for instance, the FDA approved BESREMi for the treatment of adults living with polycythemia vera, which is a recent advancement in the interferons industry.

Polycythemia vera is a group of rare, chronic, and life-threatening blood cancers caused by a mutation in bone marrow stem cells, which further leads to an abundance of blood cells. When this happens, a person is at high risk of significant health problems such as blood clots, strokes, and heart attacks.

One of the other factors driving the global interferons market is rising focus of key players on the development of innovative interferon-beta medications. Key players are also focusing on expanding their presence with the help of promotions, improved distribution networks, and enhanced customer services related to their products for the betterment of the brand and products.

For instance, in March 2020, Bayer and Curadev signed a research collaboration and license agreement to develop a novel stimulator of interferon genes (STING) antagonists across indications. It is known to help activate the innate immune system in auto-inflammatory diseases. Such breakthroughs in the global market are projected to bode well for the interferons industry in the upcoming decade.

Ask from Market Research Expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-15158

Key Takeaways: Interferons Market

By product, interferon beta is the leading segment with a market share of around 2% in 2021.
In terms of indication, the multiple sclerosis segment dominates the interferons market and held a share of around 0% in 2021.
Based on end user, hospital pharmacies are expected to lead the interferons market and it generated a share of nearly 5% in 2021.
North America is considered to be the leading region in the interferons market with a share of about 2% in 2021.

“Growing number of therapeutic interferon approvals and their surging commercial applications in several disease indications are expected to propel the global interferons market,” says an analyst of Future Market Insights.

Competitive Landscape: Interferons Market

Leading manufacturers such as Pfizer, Merck & Co., Zydus Cadila, and Novartis AG are focusing on collaborations and acquisitions to enhance their presence in the market and compete with their rivals during the forecast period. Below are some of the latest industry developments by key market participants:

In March 2022, Pfizer completed the acquisition of Arena Pharmaceuticals to expand its inflammation and immunology therapeutics segment.
In January 2022, Pfizer and Beam Therapeutics announced an exclusive collaboration to explore innovative In Vivo base editing projects for three targets in rare genetic illnesses of the liver, muscle, and central nervous system.
In January 2022, Merck & Co. completed the acquisition of Exelead and aims to invest more than € 500 million in technical scale-up. Merck’s Life Science business segment will be able to provide comprehensive end-to-end contract development and manufacturing organization (CDMO) services across the mRNA value chain as a result of the acquisition.

For in-depth insights, Download a PDF Brochure@ https://www.futuremarketinsights.com/reports/brochure/rep-gb-15158

More Valuable Insights on Interferons Market:

Future Market Insights brings a comprehensive research report on projected revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2032. The global interferons market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the interferons market segments based on product (interferon gamma, interferon beta, and interferon alpha), indication (multiple sclerosis, polycythemia vera, hepatitis C, melanoma, chronic granulomatous disease (CGD), and other indications), and end user (hospital pharmacies, retail pharmacies, specialty clinics, and online pharmacies) across seven major regions.

Interferons Market Outlook by Category

By Product:

Interferon Gamma
Interferon Beta
Interferon Alpha

By Indication:

Multiple Sclerosis
Polycythemia Vera
Hepatitis C
Melanoma
Chronic Granulomatous Disease (CGD)
Other Indications

By End User:

Hospital Pharmacies
Retail Pharmacies
Specialty Clinics
Online Pharmacies

About FMI:

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Radiopharmaceuticals Market is projected to flourish at a value CAGR of 4.3% to reach US$ 9.5 Bn by 2032 | FMI

[190 Pages] As per Future Market Insights (FMI), driven by rising cases of cancer and cardiovascular diseases, radiopharmaceutical market registered steady year-on-year growth at 4.90% CAGR in 2021.

Increasing development of radioisotopes to curb the cases of cancer have propelled the market demand, topping a valuation of US$ 6,107.2 Mn in 2021. Rising cases of prostate and breast cancer, especially in developed countries including the U.S., the U.K., and Germany, have increased the application of radiopharmaceuticals.

Increasing preference of non-invasive medical therapies and production of radioisotopes for the treatment is another factor that will stabilize the growth of radiopharmaceuticals market. Based on this, FMI projects the market is poised to expand at over 4.66% CAGR during the forecast period of 2021 and 2031.

Government initiatives and research activities undertaken to develop advanced radioisotopes for the treatment of cancer and to develop novel therapeutics will boost the demand. Also, introduction of novel technologies such as Positron Emission Technology and others in nuclear imaging systems will bolster growth.

However, due to the global shutdown witnessed in the FQ-20 in response to the COVID-19 outbreak, growth declined considerably. Suspended production of radioisotopes and disruption in the research activities delayed the deployment of projects in the healthcare sector.

Although, with increasing development activities and increasing commercialization of radiopharmaceuticals by industry giants have picked up the pace for the growth of market. Alongside this, increasing cases of cancer will accelerate the development of nuclear medicines in the field of radiopharmaceuticals.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1992

Prominent Players:

Siemens AG

Positron Corporation

Novartis (Advanced Accelerator Applications)

Curium

GE Healthcare

Lantheus Holdings Inc.

Sotera Health LLC

Bayer AG

Eckert & Ziegler

Key Takeaways from FMI’s Radiopharmaceuticals Market Study

In terms of application, oncology will contribute over 50% of global market share owing to the rising prevalence of cancer across the globe.

Cyclotrons are expected to be the primary source of radiopharmaceuticals, accounting for maximum market share

Based on radioisotope type, technetium-99 will remain highly preferred radioisotope in the global radiopharmaceutical market

The U.S. will retain its global dominance backed by the high cancer and cardiovascular cases rising in the country

India will emerge as lucrative market owing to the favorable government initiatives promoting the radiopharmaceuticals market

Germany and the U.K. are spearheading the growth of Europe market, which is projected to grow at over 4.9% CAGR

“Increasing research and development initiatives aimed at the production of advanced radioisotopes and novel technologies will improve growth prospects for the leading players in the radiopharmaceuticals market,” says the FMI analyst.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-1992

Competitive Landscape

Leading radiopharmaceuticals market players are focusing on expanding their customer base through strategic mergers and acquisition. Increasing research and development activities to develop advanced radioisotopes for the cancer treatment is another core strategy adopted by leading players.

Top 5 players including Siemens AG, GE Healthcare, Curium, Lantheus Holdings Inc., and Eckert & Ziegler are dominating the global radiopharmaceuticals market, contributing over 90% of revenue share.

In March 2021, Novartis announced the commercialization and obtained the rights to develop the therapeutic applications of Fibroblast Activation Protein (FAP) targeting agents including FAPI-46 and FAPI-74, through an assignment agreement with iTheranostics, Inc., an affiliate of SOFIE Biosciences, Inc.

Along with it the company announced the production and commercialization of new nuclear medicine, 18F sodium fluoride radiopharmaceutical in France.

In November 2020, Blue Earth Diagnostics, a leading molecular imaging diagnostic company, unveiled that their manufacturing company, Nucleis has manufactured and shipped their first doses of rhPSMA-7.3 (18F), an investigational Prostate-Specific Membrane Antigen (PSMA)-targeted radiohybrid PET imaging agent, for patients with prostate cancer.

Another industry giant, Jubilant Pharma Limited Company, in 2019, announced the integration of its radiopharmaceutical drug development and manufacturing business with its radio-pharmacy business into a global radiopharmaceutical brand, Jubilant Radiopharma.

For in-depth competitive analysis Buy Now – https://www.futuremarketinsights.com/checkout/1992

Radiopharmaceuticals Market by Category

By Radioisotope Type:

Technetium-99

Fluorine-18

Iodine-131

Leutetium-177

Yttrium-90

Gallium-68

Gallium-67

Rubidium-82

Iodine-123

Iodine-125

Indium-111

Others

By Application:

Oncology

Cardiology

Gastroenterology

Neuroendocrinology

Neurology

Nephrology

Others

By Source:

Cyclotrons

Nuclear Reactors

By End-User:

Hospitals

Diagnostic Imaging Centers

Ambulatory Surgical Centers

Cancer Research Institute

By Region:

North America

Latin America

Western Europe

Eastern Europe

Asia Pacific excluding Japan

Japan

Middle East & Africa (MEA)

About FMI:

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Magnetic Resonance Imaging (MRI) Contrast Agents Market is projected to grow 1.23 Bn by the end of 2029

[240 Pages Report] A recent market study published by Future Market Insights (FMI) on the magnetic resonance imaging (MRI) contrast agents market offers global industry analysis for 2014-2018 and opportunity assessment for 2019-2029. The report consists of a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the magnetic resonance imaging contrast agents market, growth prospects of the market are obtained with maximum precision.

The report features unique and salient factors that may make a huge impact on the development of the magnetic resonance imaging contrast agents market during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in the MRI contrast agents market in the coming years. The report provides detailed information about the current and future growth prospects of the magnetic resonance imaging contrast agents market in the most comprehensive way for better understanding of readers.

Data Points	Market Insights
Market Value 2022	U.S. $ 910.9 Mn
Market Value 2029	U.S. $ 1.23 Bn
CAGR 2022-2029	4.4%
Share of top 5 countries	60.8%

Download Sample Copy@ https://www.futuremarketinsights.com/reports/sample/rep-gb-11023

Magnetic Resonance Imaging (MRI) Contrast Agents Market : Segmentation

FMI’s study on the magnetic resonance imaging contrast agents market offers information divided into three important segments— product type, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

By Product

Paramagnetic Contrast Agents
- Extracellular Fluid (ECF) Agents
- Blood Pool Contrast Agents (BPCAs)
- Organ-specific Agents
Superparamagnetic Contrast Agent

End User

Hospitals
Ambulatory Surgical Centers
Diagnostic Centers

Region

North America
Latin America
Europe
South Asia
East Asia
Oceania
MEA

Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-11023

Chapter 1 – Executive Summary

The report commences with the executive summary of the MRI contrast agents market report, which includes the summary of key findings and statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the magnetic resonance imaging contrast agents market, as well as the key trends impacting the market.

Chapter 2 – Market Overview

Readers can find detailed taxonomy, definition of the magnetic resonance imaging contrast agents market, and the key inclusions and exclusions in this chapter, which help readers understand basic information about MRI contrast agents.

Chapter 3 – Key Market Trends

This section highlights the key trends impacting the magnetic resonance imaging contrast agents market, which will help readers understand the current trends and their impact on market growth.

Chapter 4 – Key Success Factors

In this chapter, the reader can get information about the parent market of MRI contrast agents market. Novel use cases, product adoption by region, product USPs, number of scans by country, and how combination imaging modalities will enhance medical imaging.

Chapter 5 – Global Magnetic Resonance Imaging Contrast Agents Market Volume (In Liters) Analysis 2014-2018 and Forecast, 2019-2029

This section explains the current and future market volume (In Liters) projections and the growth trend. Readers can also get knowledge the current installed base of MRI Units, by region/ country and historical market volume (In Liters) of global magnetic resonance imaging (MRI) contrast agents market.

Chapter 6 – Global Magnetic Resonance Imaging Contrast Agents Market – Pricing Analysis

The report covers the pricing analysis of the market on the basis of region and other attributes in this chapter. It will help the reader find comparative analysis of product pricing across different regions of the globe.

Buy Complete Report@ https://www.futuremarketinsights.com/checkout/11023

Chapter 7 – Global Magnetic Resonance Imaging Contrast Agents Market Value (US$) Analysis 2014-2018 and Forecast, 2019-2029

This section explains the global market value analysis and forecast for the MRI contrast agents market during the forecast period of 2019-2029. Along with the historical market and opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019–2029).

About FMI:

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs